Similar to the dynamic seen in many U.S. states and Canadian provinces, Italy bought significantly more cannabis in 2019 than in the previous year. Citing official government statistics, Marijuana Business Daily reported that the volume of cannabis sold in the country rose almos
Eli Lilly (NYSE: LLY) is one of the many drugmakers that have been looking to develop a treatment for COVID-19, and the company recently announced it was making progress in its efforts to do so. Eli Lilly partnered up with the National Institute of Allergy and Infectious Disease
Ontario, the most populous out of Canada's 10 provinces, could potentially be the one most populated with marijuana dispensaries. According to data provided to Marijuana Business Daily by the province's Alcohol and Gaming Commission, it has received almost 900 applications for r
A leading medical journal recently published an analysis of coronavirus patients treated with remdesivir, an experimental antiviral from Gilead Sciences (NASDAQ: GILD). While the data doesn't tell us much that we didn't know already, it did pour cold water on any lofty expecta
Emergency funds help you cover costs when you experience an unexpected drop in income or surprise increases in expenses. For millions of Americans, an emergency has arrived with the coronavirus crisis and resulting job losses.
Restaurant stocks have been among the hardest hit from the COVID-19 shutdown. As governments ordered restaurants to stop seating customers, the market responded by whacking the stocks.
Investors have sold off energy stocks over the past month because of plunging oil prices following the COVID-19 outbreak. Driving down pricing is a massive disruption in demand for oil and refined products because governments around the world have issued stay-at-home orders to s
Trading on a major exchange can give a company access to a significant pool of investors, meaning easier access to funding and expedited growth. That's why listing on an exchange like the NYSE or NASDAQ is the goal for many pot stocks. However, with marijuana still illegal at th
Besides working on a vaccine for the coronavirus, British American Tobacco (NYSE: BTI) is one of the top three tobacco companies in the world, alongside Altria Group and Philip Morris International.
There are quite a few companies that have found ways to grow their business during the ongoing COVID-19 pandemic. This is especially true for a number of biotechs now working on developing a potential treatment for, or vaccine against, the virus; shares of such companies have la
Small-cap vaccine manufacturers have been some of the most volatile stocks on the market. As demand for a COVID-19 vaccine continues to grow, many companies working on potential treatments have seen their shares double or triple since the start of 2020.
Spirit AeroSystems (NYSE: SPR) has halted work on Boeing (NYSE: BA) commercial aircraft fuselages and furloughed more than 3,000 workers for 21 days following Boeing's decision to suspend final assembly due to the COVID-19 coronavirus pandemic.
Believe it or not, there will come a time when the coronavirus contagion is in the rearview mirror. For a few people, life will have changed dramatically. For most people, life will have changed at least a little. Whether it be due to a job loss, concern about the cleanliness of
Cannabis sales were soaring in March, especially during the first half of the month as the coronavirus became a global pandemic. Washington state saw a 9% increase in March's revenue from cannabis compared to the prior year, California's sales were up 53% year over year (althoug
When a company develops products that should be game changers in the way cancer is treated, it's going to generate a lot of buzz. That's exactly what has happened for Guardant Health (NASDAQ: GH).
In most years, April isn't a special month to buy stocks. It's not a bad time to invest, but there's nothing that makes April better than other months. But this April is different.
In most years, April isn't a special month to buy stocks. It's not a bad time to invest, but there's nothing that makes April better than other months. But this April is different.
Inovio Pharmaceuticals (NASDAQ: INO) has been making a lot of headlines lately. Thanks to its efforts to develop a vaccine for COVID-19, the company's stock is up by 150% year to date.